Page 342 - 73_04

M.ª TERESA MIRAS-PORTUGAL Y COLS. ANAL. REAL ACAD. NAC. FARM.

(12) VAN KOLEN, K. AND SLEGERS, H. (2006) Integration of P2Y receptor-activated
(13) signal transduction pathways in G protein-dependent signaling networks.
(14) Purinergic Signalling. 2: 451-469.
(15) HARDEN, T.K.; BOYER, J.L. AND NICHOLAS, R.A. (1995) P2-purinergic receptors:
(16) subtype-associated signalling responses and structure. Annu. Rev. Pharma-
(17) col. Toxicol. 35: 541-549.
(18) COMMUNI, D.; GOVAERTS, C.; PARMENTIER, M. AND BOEYNAEMS, J.M. (1997) Clo-
(19) ning of a human purinergic P2Y receptor coupled to phospholipase C and
adenyly cyclase. J. Biol. Chem. 272: 31969-31973.
(20) COMMUNI, D.; ROBAYE, B.M. AND BOEYNAEMS, J.M. (1999). Pharmacological cha-
(21) racterization of the human P2Y11 receptor. Br. J. Pharmacol. 128: 1199-1206.
VON KÜGELGEN, I. AND WETTER, A. (2000) Molecular pharmacology of P2Y-
(22) receptors. Naunyn Schmiedeberg´s Arch. Pharmacol. 362: 310-323.
KOTEVIC, I.; KIRSCHNER, K.M.; PORZIG, H. AND BALTENSPERGER, K. (2005). Consti-
(23) tutive interaction of the P2Y2 receptor with the hematopoietic cell-specific G
(24) protein G(a16) and evidence for receptor oligomers. Cell Signall. 17: 869-880.
(25) ROBERTS, J.A.; VIAL, V.C.; DIGBY, H.R.; AGBOH, K.C.; WEN, H.; ATTERBURY-THO-
MAS, A. AND EVANS, R.J. (2006) Molecular properties of P2X receptors. Pflu-
(26) gers Arch. 452: 486-500.
COLLO, G.; NORTH, R.A.; KAWASHIMA, E.; MERLO-PICH, E.; NEIDHART, S.; SURPRE-
NANT, A. AND BUELL, G. (1996) Cloning of P2X5 and P2X6 receptors and the
distribution and properties of an extended family of ATP-gated ion chan-
nels. J. Neurosci. 16: 2495-2507.
SOTO, F.; GARCÍA-GUZMÁN, M.; KARSCHIN, C. AND STUHMER, W. (1996) Cloning
and tissue distribution of a novel P2X receptor from rat brain. Biochem.
Biophys. Res. Commun. 223: 456-460.
VULCHANOVA, L.; RIEDL, M.; SHUSTER, S. J.; BUELL, G.; SURPRENANT, A.; NORTH,
R. A. AND ELDE, R. (1997) Immunohistochemical study of the P2X2 and P2X3
receptor subunits in rat and monkey sensory neurons and their central ter-
minals. Neuropharmacology. 36: 1229-1242.
VULCHANOVA, L.; RIEDL, M.; SHUSTER, S.J.; STONE L.S.; HARGREAVES, K.M.; BUE-
LL, G.; SURPPRENANT, A.; NORTH, R.A. AND ELDE, R. (1998) P2X3 is expressed by
DGR neurons that terminate in inner lamina II. Eur. J. Neurosci. 10: 3470-
3478.
NORTH, R.A. AND SURPRENANT, A. (2000) Pharmacology of cloned P2X recep-
tors. Annu. Rev. Pharmacol. Toxicol. 40: 563-80.
NÖRENBERG, W. AND ILLES, P. (2000) Neuronal P2X receptors: localization and
functional properties. Naunyn Schmiedebergs Arch Pharmacol. 362: 324-339.
KHAKH, B.S.; BURNSTOCK, G.; KENNEDY, C.; KING, B.F.; NORTH, R.A.; SÉGUÉLA, P.;
VOIGT, M. AND HUMPHREY, P.P. (2001). International Union of Pharmacology,
XXIV, current status of the nomenclature and properties of P2X receptors
and their subunits. Pharmacol. Rev. 53: 107-118.
WILEY, J.S.; DAO-UNG, L.P.; CHANGPING, L.; SHEMON, A.N.; GU, B.J.; SMART,
M.L.; FULLER, S-J.; BARDEN, J.A.; PETROU, S. AND. SLUYTER, R. (2003) An Ileu-
568 to Asn polymorfism prevents normal trafficking and function of the
human P2X7 receptor. J. Biol. Chem. 278: 17180-17113.

1152